QST Consultations, Ltd. Chooses Omnicomm Systems, Inc. For Electronic Data Capture (EDC) In A Top 15 Pharmaceutical, Phase IV Clinical Trial
OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, recently announced that QST Consultations, Ltd. has selected OmniComm's integrated EDC solution, TrialMaster, for a Phase IV, multi-site international allergy study. QST is a Contract Research Organization (CRO) that provides clinical trial support for the pharmaceutical and medical device industries. QST has successfully used TrialMaster for EDC clinical trial support in the past and has recently joined OmniComm's CRO Preferred Program.
"QST's clients range from small start-ups to large major pharmaceutical companies that conduct complex clinical studies and they all expect and deserve a superior level of personalized service, technical expertise and quality deliverables. We have selected OmniComm as our partner to provide EDC because having worked with them in the past we knew that they were a good match to satisfy our clients' expectations," said John Quiring, Ph.D., President of QST Consultations. "It is important for us to use a full service EDC provider whose capabilities include both a strong technology product and support services that complement our own efforts."
QST Consultations, Ltd. is an independent consulting firm that specializes in clinical study design, protocol development, CRF design, data management, biostatistical analysis, report writing services and statistical consultation services for the medical device and pharmaceutical industries. QST Consultations has been involved in many successful Phase I through Phase IV clinical trials in support of 510 (k), PMA, ANDA, and NDA submissions. QST's primary focus is to meet the goals of each client through personalized service and technical expertise. QST Consultations, Ltd. was founded in 1974 and incorporated in 1985.
"It gives us great satisfaction to know that QST has chosen TrialMaster with confidence for their EDC needs for this important clinical trial. At OmniComm, we are diligent about delivering solutions that exceed expectations for all of our customers and it is proof positive that we are delivering superior solutions as promised when important clients like QST choose us for repeat business," said Stephen Johnson, Executive Vice President of Business Development, Professional Services and Client Services and Support.
About OmniComm
OmniComm Systems, Inc. provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments.
OmniComm ranked in the top 150 as one of the fastest revenue growth technology companies in North America during the last 5 years. OmniComm Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Germany, Tula, Russia, California, Maryland, New York, North Carolina and Texas.
SOURCE: OmniComm Systems, Inc.